Found: 4
Select item for more details and to access through your institution.
Safety of oral afoxolaner formulated with or without milbemycin oxime in homozygous MDR1‐deficient collie dogs.
- Published in:
- Journal of Veterinary Pharmacology & Therapeutics, 2022, v. 45, n. 4, p. 373, doi. 10.1111/jvp.13064
- By:
- Publication type:
- Article
Plasma chemistry reference intervals for adult multi‐drug‐resistance gene deficient Collies.
- Published in:
- Veterinary Clinical Pathology, 2023, v. 52, n. 4, p. 737, doi. 10.1111/vcp.13286
- By:
- Publication type:
- Article
Concurrent Validation of MI-CAT(V), a Clinical Metrology Instrument for Veterinarians Assessing Osteoarthritis Pain in Cats, through Testing for Firocoxib Analgesic Efficacy in a Prospective, Randomized, Controlled, and Blinded Study.
- Published in:
- Animals (2076-2615), 2024, v. 14, n. 5, p. 711, doi. 10.3390/ani14050711
- By:
- Publication type:
- Article
Development of Two Innovative Performance-Based Objective Measures in Feline Osteoarthritis: Their Reliability and Responsiveness to Firocoxib Analgesic Treatment.
- Published in:
- International Journal of Molecular Sciences, 2022, v. 23, n. 19, p. 11780, doi. 10.3390/ijms231911780
- By:
- Publication type:
- Article